Flexion Therapeutics/ US33938J1060 /
18/11/2021 00:00:00 | Chg. - | Volume | Bid- | Ask- | High | Low |
---|---|---|---|---|---|---|
9.12USD | - | 18.72 mill. Turnover: - |
-Bid Size: - | -Ask Size: - | 9.23 | 9.12 |
GlobeNewswire
07/05
Pacira BioSciences Reports First Quarter 2024 Financial Results and Announces $150 Million Share Rep...
GlobeNewswire
15/03/2022
Pacira BioSciences Reports Preliminary Net Product Sales for EXPAREL and iovera° of $42.6 Million f...
GlobeNewswire
01/03/2022
Xenon Pharmaceuticals Reports 2021 Financial Results and Provides Corporate Update
GlobeNewswire
24/02/2022
Pacira BioSciences Reports Full-Year and Fourth Quarter 2021 Financial Results
GlobeNewswire
06/01/2022
Pacira Reports Preliminary Unaudited Total Revenue for 2021 of $540.7 Million to $541.7 Million
GlobeNewswire
20/12/2021
Finch Therapeutics Appoints Joseph Vittiglio, JD, as Chief Business and Legal Officer
GlobeNewswire
07/12/2021
Pacira BioSciences Reports Preliminary Net Product Sales for EXPAREL® and iovera° of $48.0 Million f...
GlobeNewswire
19/11/2021
Pacira BioSciences Completes Acquisition of Flexion Therapeutics and Strengthens Leadership Position...
GlobeNewswire
09/11/2021
Pacira BioSciences Reports Preliminary Net Product Sales of $44.3 Million for October 2021
GlobeNewswire
04/11/2021
Entasis Therapeutics Announces Third Quarter 2021 Financial Results and Provides Business Update
GlobeNewswire
01/11/2021
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates GWB, COLB, FTSI, FLXN; Shareholders are Enc...
GlobeNewswire
22/10/2021
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates ESBK, FLXN, COLB, CXP; Shareholders are Enc...
GlobeNewswire
21/10/2021
Bragar Eagel & Squire, P.C. Announces that it Is Investigating the Boards of Directors of Meredith C...
GlobeNewswire
21/10/2021
Lifshitz Law Firm, P.C. Announces Investigation of ADMS, ACBI, FLXN, and HBMD